Monarch Partners Asset Management’s Dynavax Technologies DVAX Stock Holding History

Monarch Partners Asset Management’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$1.3M	Buy	+121,879	New	+$1.42M	0.38%	119

Other funds holding DVAX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Monarch Partners Asset Management's DVAX Position: Q4 2022 in Review

Monarch Partners Asset Management opened a new position in Dynavax Technologies (DVAX) in Q4 2022: 121,879 shares worth $1.3M. The stake represents 0.38% of the portfolio and ranks #119 among its holdings.

230 funds tracked by Wall St. Rank hold DVAX as of Q4 2022.

Monarch Partners Asset Management held 121,879 shares of Dynavax Technologies worth $1.3M as of Q4 2022.
Dynavax Technologies was a new Monarch Partners Asset Management position in Q4 2022.
Dynavax Technologies made up 0.38% of Monarch Partners Asset Management's portfolio in Q4 2022, its #119 holding.
230 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2022.

Based on Monarch Partners Asset Management's 13F filing for Q4 2022, filed 2 Feb 2023.